News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Week in Review: Summer Slump for News



7/30/2008 3:58:36 PM

July 26, 2008 -- The news flow from the China biomedical sector slowed considerably last week, probably the summer doldrums. We published the second part of our guest article that updates proposed patent law changes. GSK (NYSE: GSK) completed an unusual deal with generic manufacturer, Aspen PharmaCare; MedMira (TSX Venture: MIR) (NSDQ: MMIRF) received a China patent for its diagnostic device and assay; GNI Ltd. (TOKYO: 2160) of Japan in-licensed a late-stage hepatitis drug from EpiCept (NSDQ: EPCT); and Genelabs Technologies (NSDQ: GNLB) will collaborate with Taiwan’s National Health Research Institutes and Genovate Biotechnology of Taiwan to develop drugs for hepatitis C virus. More details...

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES